Revolution Medicines, Warrant Stock Buy Hold or Sell Recommendation
| RVMDW Stock | 0.10 0.01 9.09% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Revolution Medicines, Warrant is 'Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Revolution Medicines, Warrant given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Revolution Medicines, Warrant, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Revolution Medicines, Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Revolution and provide practical buy, sell, or hold advice based on investors' constraints. Revolution Medicines, Warrant. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
Revolution |
Execute Revolution Medicines, Buy or Sell Advice
The Revolution recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Revolution Medicines, Warrant. Macroaxis does not own or have any residual interests in Revolution Medicines, Warrant or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Revolution Medicines,'s advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Revolution Medicines, Trading Alerts and Improvement Suggestions
| Revolution Medicines, generated a negative expected return over the last 90 days | |
| Revolution Medicines, has high historical volatility and very poor performance | |
| Revolution Medicines, has some characteristics of a very speculative penny stock | |
| Revolution Medicines, has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (600.09 M) with loss before overhead, payroll, taxes, and interest of (592.23 M). | |
| Revolution Medicines, generates negative cash flow from operations | |
| Revolution Medicines, has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Revolution Medicines Reports Fourth Quarter and Full Year 2024 Financial Results and Update on Corporate Progress - GlobeNewswire |
Revolution Medicines, current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Revolution analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Revolution analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Revolution Medicines, Returns Distribution Density
The distribution of Revolution Medicines,'s historical returns is an attempt to chart the uncertainty of Revolution Medicines,'s future price movements. The chart of the probability distribution of Revolution Medicines, daily returns describes the distribution of returns around its average expected value. We use Revolution Medicines, Warrant price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Revolution Medicines, returns is essential to provide solid investment advice for Revolution Medicines,.
| Mean Return | -0.09 | Value At Risk | -29.41 | Potential Upside | 36.84 | Standard Deviation | 19.74 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Revolution Medicines, historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Revolution Medicines, Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Investments | (234.2M) | (142.1M) | (24.1M) | (342.6M) | (554.4M) | (526.7M) | |
| Change In Cash | 88.5M | 4.9M | 52.9M | 536.0M | (152.4M) | (144.8M) | |
| Free Cash Flow | (103.0M) | (153.7M) | (235.2M) | (358.3M) | (567.7M) | (539.4M) | |
| Depreciation | 6.5M | 7.3M | 9.7M | 9.3M | (43.5M) | (41.3M) | |
| Capital Expenditures | 2.9M | 6.5M | 10.8M | 7.7M | 10.3M | 7.5M | |
| Net Income | (108.2M) | (187.1M) | (248.7M) | (436.4M) | (600.1M) | (570.1M) | |
| End Period Cash Flow | 105.4M | 110.2M | 163.1M | 699.2M | 546.8M | 302.5M |
Revolution Medicines, Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Revolution Medicines, or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Revolution Medicines,'s price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Revolution stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.22 | |
β | Beta against Dow Jones | 2.51 | |
σ | Overall volatility | 21.55 | |
Ir | Information ratio | 0 |
Revolution Medicines, Volatility Alert
Revolution Medicines, Warrant is displaying above-average volatility over the selected time horizon. Revolution Medicines, Warrant is a potential penny stock. Although Revolution Medicines, may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Revolution Medicines, Warrant. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Revolution instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Revolution Medicines, Fundamentals Vs Peers
Comparing Revolution Medicines,'s fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Revolution Medicines,'s direct or indirect competition across all of the common fundamentals between Revolution Medicines, and the related equities. This way, we can detect undervalued stocks with similar characteristics as Revolution Medicines, or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Revolution Medicines,'s fundamental indicators could also be used in its relative valuation, which is a method of valuing Revolution Medicines, by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Revolution Medicines, to competition |
| Fundamentals | Revolution Medicines, | Peer Average |
| Return On Equity | -0.29 | -0.31 |
| Return On Asset | -0.19 | -0.14 |
| Number Of Shares Shorted | 2.25 K | 4.71 M |
| Gross Profit | (592.23 M) | 27.38 B |
| EBITDA | (689.52 M) | 3.9 B |
| Net Income | (600.09 M) | 570.98 M |
| Total Debt | 135.84 M | 5.32 B |
| Book Value Per Share | 12.19 X | 1.93 K |
| Cash Flow From Operations | (557.44 M) | 971.22 M |
| Number Of Employees | 534 | 18.84 K |
| Beta | 1.46 | -0.15 |
| Total Asset | 2.56 B | 29.47 B |
| Retained Earnings | (1.74 B) | 9.33 B |
| Working Capital | 2.16 B | 1.48 B |
| Net Asset | 2.56 B |
Revolution Medicines, Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Revolution . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 67.36 | |||
| Daily Balance Of Power | (1.00) | |||
| Rate Of Daily Change | 0.91 | |||
| Day Median Price | 0.11 | |||
| Day Typical Price | 0.1 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) |
About Revolution Medicines, Buy or Sell Advice
When is the right time to buy or sell Revolution Medicines, Warrant? Buying financial instruments such as Revolution Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Revolution Medicines, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Munis Funds Thematic Idea Now
Munis Funds
Funds or Etfs that invest in fixed income securities issued by states, cities, and towns as well as other public entities. The Munis Funds theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Munis Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Revolution Stock Analysis
When running Revolution Medicines,'s price analysis, check to measure Revolution Medicines,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines, is operating at the current time. Most of Revolution Medicines,'s value examination focuses on studying past and present price action to predict the probability of Revolution Medicines,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines,'s price. Additionally, you may evaluate how the addition of Revolution Medicines, to your portfolios can decrease your overall portfolio volatility.